Upcoming biotech clinical-trial catalysts (?ticker=<biotech ticker> or ?company=
Upcoming biotech clinical-trial catalysts (?ticker=<biotech ticker> or ?company=)
Answeringour last check, 2026-09-24
1 of 1checks answered this week
875 msmedian answer time
$0.05listed price per call
$0.05price it asked us
Paid test badge: not yet. The checks above are free: we call the tool without paying and read the payment request it sends back. The Verified badge needs paid calls whose answers match the promised output, and nobody can buy a badge.
Endpoint
GET https://pharma.lonestaroracle.xyz/catalysts
| Category | Company and compliance |
|---|---|
| Provider host | pharma.lonestaroracle.xyz |
| Networks | eip155:8453, solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp |
| Payment schemes | exact |
| Self-reported calls, 30 days | 3 from 1 payers (the provider's figure, not ours) |
Our checks, last 30 days
| Day | Result | HTTP | Asked | Time |
|---|---|---|---|---|
| 2026-09-24 | valid payment request | 402 | $0.05 | 875 ms |
Example input (from the provider)
{
"method": "GET",
"queryParams": {
"company": "NVIDIA",
"days": 365,
"ticker": "SRPT"
},
"type": "http"
}
Promised output schema (from the provider)
{
"category": "markets",
"description": "Biotech catalyst tracking made agent-callable. One x402 call takes a stock ticker (or company name) and returns a catalyst signal (HIGH / MODERATE / LOW / NONE) plus the company's upcoming late-stage clinical-trial readouts \u2014 the binary events that move biotech stocks 50-90% in a day. Each catalyst names the phase (2 or 3), the indication, the expected primary-completion date (the data-release proxy), how many days out it is, the trial status and the ClinicalTrials.gov NCT id. The biotech analog of an earnings calendar, served pay-per-call: a trading, research or risk agent asks 'what's coming for $SRPT' and gets the readout schedule. $0.05 in USDC on Base via x402. Sources: ClinicalTrials.gov API v2 (official) + yfinance for ticker resolution (all free/public). NOTE: this is the trial-readout leg \u2014 it does NOT include curated FDA PDUFA decision dates (no free feed exists for those). Companion to EquityScope, OptionsFlow, AnalystEdge and EarningsCalendar.",
"name": "PharmaCatalyst",
"properties": {
"input": {
"properties": {
"method": {
"enum": [
"GET",
"HEAD",
"DELETE"
],
"type": "string"
},
"queryParams": {
"properties": {
"company": {
"description": "Company name instead of a ticker (e.g. 'Vertex Pharmaceuticals'). Alias: name.",
"type": "string"
},
"days": {
"default": 365,
"description": "Look-ahead horizon in days (default 365, max 1095). Alias: horizon.",
"type": "integer"
},
"ticker": {
"description": "Biotech stock ticker (e.g. SRPT, VRTX, MRNA). Resolved to a company via yfinance. Alias: symbol.",
"example": "SRPT",
"type": "string"
}
},
"type": "object"
},
"type": {
"const": "http",
"type": "string"
}
},
"required": [
"type",
"method"
],
"type": "object"
},
"output": {
"properties": {
"example": {
"catalyst_signal": "HIGH",
"company": "Sarepta Therapeutics, Inc.",
"counts": {
"next_90d": 1,
"phase2": 0,
"phase3": 2,
"total_upcoming": 2
},
"horizon_days": 365,
"interpretation": "Near-term binary catalyst risk: a Phase 3 readout (or several trials) due within 90 days.",
"match": "sponsor",
"source": "ClinicalTrials.gov API v2",
"sponsor_query": "Sarepta",
"ticker": "SRPT",
"upcoming_catalysts": [
{
"days_out": 84,
"expected_readout": "2026-10-31",
"indication": "Muscular Dystrophy, Duchenne",
"lead_sponsor": "Sarepta Therapeutics, Inc.",
"nct_id": "NCT03992430",
"phase": "Phase 3",
"source": "ClinicalTrials.gov",
"status": "Recruiting",
"type": "Trial Readout"
}
]
},
"type": {
"type": "string"
}
},
"required": [
"type"
],
"type": "object"
}
},
"required": [
"input"
],
"tags": [
"biotech",
"pharma",
"catalyst",
"clinical-trials",
"healthcare"
],
"type": "object",
"version": "1.0.0"
}